WHO, together with heads of state, global leaders, private sector partners and other stakeholders launched the Access To COVID-19 Tools (ACT) Accelerator, a global collaboration to accelerate the development, production and equitable access to new COVID-19 diagnostics, therapeutics and vaccines, details
WHO has seen a dramatic increase in the number of cyber-attacks directed at its staff, and email scams targeting the public. WHO has urged the public to remain vigilant against fraudulent emails and recommends using reliable sources to obtain information about COVID-19 and other health issues
WHO Country Office for India (WCO) continues to work closely with MoHFW, on preparedness and response
measures for COVID-19, including surveillance and contact tracing, laboratory diagnosis, risk communications and
community engagement, hospital preparedness, infection prevention and control (IPC) and implementation of
• Co-ordination and Partnership: WCO hosted the Health Partners virtual meeting to facilitate consensus and
draft implementation strategy to support the MHFW as ‘One UN’ through the Joint Response Plan.
• Laboratory testing: WHO is providing kits and reagents to COVID-19 testing laboratories through ICMR to
partly meet their huge testing requirement. A total of 625 309 samples have been tested so far, details here.
o ICMR had clearly laid down the scope, purpose and usage of the rapid antibody tests. ICMR has
always emphasized that the confirmatory test for diagnosis of COVID-19 infection is RT – PCR test of
throat and/ or nasal swab, which detects virus at early stage, details here.
o ICMR expanded the testing strategy to pregnant women residing in clusters/containment area or in
large migration gatherings/evacuees centre from hotspot districts presenting in labour or likely to
deliver in next 5 days should be tested even if asymptomatic, details here.
• Surveillance: SARI surveillance is being strengthened in states with support from WCO field staff. SMOs in the
field are facilitating CIF filling and IHIP portal data entry along with following up on SARI/ILI surveillance.
• Research: ICMR had announced conducting a national sero-prevalence survey for Covid-19. WCO field teams
are supporting states in the initial preparations for undertaking the proposed Survey.
o India has joined the WHO Solidarity Trial for therapeutic treatment options for COVID 19. The trial has
received clearance from the regulatory authority of India to move ahead with the trial.
• Risk Communication: WHO is supporting MoHFW on a Campaign to address the issue of stigma, in the
society both against COVID positive cases and the medical community.
• State Support: WCO is supporting states through field teams and is now in the process of creating a pool for
experts to be part of rapid response teams for special deployment.
Government of India and WHO partnership further strengthened to overcome the COVID-19 challenge
Dr Harsh Vardhan, Union Health Minister lauds the efforts of field surveillance ‘corona warriors’
“Time and again the Government of India and WHO together have shown our ability, competence and prowess to the whole world. With our combined meticulous work, done with full sincerity and dedication, we were able to get rid of polio. Today I would like to remind you of your potential and ability, and the big things we can do together. All of you in the field – Integrated Disease Surveillance Programme (IDSP), state rapid response teams and WHO – are our ‘surveillance corona warriors’. With your joint efforts we can defeat the coronavirus and save lives,” said Dr Harsh Vardhan, Minister of Health & Family Welfare, Government of India at a virtual meeting held in New Delhi